Biogen Snaps Up Apellis For $5.6 Billion, Adding Two New Drugs To Its Portfolio
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information solely for informational and educational purposes and does not offer investment advice or recommendations.
- The data is sourced from what are considered reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance is not indicative of future results, and authors may hold positions in the stocks they discuss.
- The company disclaims warranties regarding the advisability of specific securities or investment strategies, and information may change without notice.
- Real-time pricing data is provided by Nasdaq Last Sale, with ownership and estimate data from LSEG and FactSet, and all trademarks are owned by Investor’s Business Daily, LLC.
![Pixel 11 Pro is thinner, but mostly the same in first leak [Gallery]](https://media-cdn.cashwalklabs.io/https%3A%2F%2Fi0.wp.com%2F9to5google.com%2Fwp-content%2Fuploads%2Fsites%2F4%2F2026%2F03%2Fgoogle-pixel-11-pro-onl-2.webp%3Fresize%3D1200%252C628%26quality%3D82%26strip%3Dall%26ssl%3D1?format=webp&w=120&h=80){kind=tracking}
